From Data to Dose: Diversity in Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy

Q: What type of study is this?

This is a Literature Review study.

Gellért Karvaly; Barna Vásárhelyi

doi:10.3390/pharmaceutics17081083

August 21, 2025PharmaceuticsOpen Access

From Data to Dose: Diversity in Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy

View Full Paper

Ask AI

Bookmark

Share

Key Points

Diversity in therapeutic drug monitoring potentially enhances drug efficacy and patient outcomes.
Recent evaluations show varied pharmacokinetics approaches impacting treatment effectiveness across patient groups.
Assessment using pharmacokinetics measurements indicates significant variations in individual responses to drug therapy.
Individualization may support tailored therapeutic strategies, emphasizing personalized medicine for better healthcare.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Observational analysis reveals diversity in therapeutic drug monitoring and pharmacokinetics-based approaches, suggesting improved outcomes for patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Karvaly et al. (2025) studied this question.

synapsesocial.com/papers/68af5210ad7bf08b1ead9727 https://doi.org/10.3390/pharmaceutics17081083

View Full Paper

Ask AI

Bookmark

Share

From Data to Dose: Diversity in Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy

Key Points

No abstract yet

Implication

Discussion

Cite This Study

From Data to Dose: Diversity in Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Keep reading

Keep reading